Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Immunotech Biopharm Ltd ( (HK:6978) ) just unveiled an announcement.
Immunotech Biopharm Ltd has announced the composition of its board of directors and the roles they will undertake. The board includes executive, non-executive, and independent non-executive directors, and has established three committees: Audit, Remuneration, and Nomination, each with designated members. This announcement is significant for stakeholders as it outlines the governance structure and leadership roles, which are crucial for strategic decision-making and operational oversight.
More about Immunotech Biopharm Ltd
Immunotech Biopharm Ltd is a company incorporated in the Cayman Islands, operating in the biopharmaceutical industry. The company focuses on developing innovative therapies and products, with a market focus on advancing healthcare solutions.
Average Trading Volume: 1,295,038
Technical Sentiment Signal: Buy
Current Market Cap: HK$2.62B
For detailed information about 6978 stock, go to TipRanks’ Stock Analysis page.